ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluriaGema Ariceta, Gesa Schalk, Saoussen Abroug et al.|Pediatric Nephrology|2022Cited by 21